The realization that the mutations underlying GNAO1 encephalopathy are neomorphic (as opposed to the more traditional loss- or gain-of-function dichotomy) suggests reconsidering the genetic basis of many other genetic diseases linked to mutations in genes encoding Gα subunits, but also in unrelated genes. This evidence concerns the gene GNAO1 and Encephalopathy.